Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where J. Wild is active.

Publication


Featured researches published by J. Wild.


Biomedical Chromatography | 1996

Determination of Plasma Total Homocysteine and Cysteine Using HPLC with Fluorescence Detection and an Ammonium 7‐fluoro‐2,1,3‐benzoxadiazole‐4‐sulphonate (SBD‐F) Derivatization Protocol Optimized for Antioxidant Concentration, Derivatization Reagent Concentration, Temperature and Matrix pH

I. Daskalakis; Mark Lucock; A. Anderson; J. Wild; C.J. Schorah; M.I. Levene

A sensitive HPLC-fluorescence method for determining total endogenous plasma homocysteine (Hcy), cysteine (Cys) and cysteinylglycine (Cys-Gly) following derivatization with ammonium 7-fluoro 2,1,3-benzoxadiazole-4-sulphonate (SBD-F) is described. Quantitation utilizes an internal standard, 2-mercaptoethylamine. The derivatization procedure has been optimized for concentration of SBD-F, reducing agent (tributylphosphine) and temperature. Findings indicate that values for plasma determinations vary according to the nature of the matrix in which calibration standards are made up. If quantitation is based on a peak height ratio, then standards should be made up in either pH 7.4 phosphate buffered saline or plasma taking into account the endogenous thiol concentration. These findings are based on calibration data, and 30 plasma samples quantified using thiol standards made up in plasma, pH 7.4 and pH 9.5 buffers. By defining how this matrix/pH effect influences thiol quantitation, it should be possible to make a more meaningful comparison of Hcy measurements between laboratories. The chromatographic separation was investigated at several mobile-phase pH values with the following conditions ascertained to be optimal: a mobile phase consisting of 5% (v/v) acetonitrile in 0.1 M KH2PO4, pH 2.15 was run at a flow rate of 0.5 mL/min. It was used in conjunction with a Supelco LC-18 base deactivated analytical column (150 x 4.6 cm i.d. 3 microM bonded silica). The internal standard and thiols were measured by fluorescence detection at 385 nm excitation and 515 nm emmission. Plasma levels are easily measured in a 100 microL volume. Storage for 2 months at -20 degrees C resulted in no deterioration of thiols. Furthermore, no difference in thiol levels was observed between bloods collected in lithium heparin and EDTA. Collected blood should, however, be separated as soon as possible to avoid red cell metabolism of Hcy which was observed in a case of hyperhomocysteinemia. Once derivatized, thiols are stable for at least one week at +4 degrees C.


The Lancet | 1989

PREVENTION OF NEURAL TUBE DEFECT RECURRENCES IN YORKSHIRE: FINAL REPORT

R. W. Smithells; Sheila Sheppard; J. Wild; C.J. Schorah


Biochemical and Molecular Medicine | 1995

Nonenzymatic Degradation and Salvage of Dietary Folate: Physicochemical Factors Likely to Influence Bioavailability

Mark Lucock; M. Priestnall; I. Daskalakis; C.J. Schorah; J. Wild; M.I. Levene


Biochemical Medicine and Metabolic Biology | 1994

The Methylfolate Axis in Neural Tube Defects: In Vitro Characterization and Clinical Investigation

Mark Lucock; J. Wild; C.J. Schorah; M.I. Levene; R. Hartley


European Journal of Clinical Nutrition | 1989

Biotransformation of pteroylmonoglutamic acid during absorption: implications of Michaelis-Menten kinetics.

Mark Lucock; J. Wild; Smithells R; R. Hartley


Molecular Genetics and Metabolism | 1999

FOLATE-HOMOCYSTEINE INTERRELATIONS : POTENTIAL NEW MARKERS OF FOLATE STATUS

Mark Lucock; I. Daskalakis; C.J. Schorah; C.H. Lumb; M. Oliver; H. Devitt; J. Wild; A.C. Dowell; M.I. Levene


Biochemical and Molecular Medicine | 1997

Risk of Neural Tube Defect-Affected Pregnancy Is Associated with a Block in Maternal One-Carbon Metabolism at the Level ofN-5-Methyltetrahydrofolate:Homocysteine Methyltransferase

Mark Lucock; J. Wild; C.H. Lumb; M. Oliver; R. Kendall; I. Daskalakis; C.J. Schorah; M.I. Levene


The Lancet | 1983

VITAMINS AND NEURAL TUBE DEFECTS

GodfreyP. Oakley; MyronJ. Adams; LevyM. James; R.W. Smithells; MaryJ. Seller; D.W. Fielding; N.C. Nevin; A.P. Read; R. Harris; C.J. Schorah; S. Sheppard; S. Walker; J. Wild


Biochemical and Molecular Medicine | 1996

The Influence of Dietary Folate and Methionine on the Metabolic Disposition of Endotoxic Homocysteine

Mark Lucock; I. Daskalakis; J. Wild; A. Anderson; C.J. Schorah; M.E.J. Lean; M.I. Levene


The Lancet | 1995

Enzyme defect as a risk factor for spina bifida

Mark Lucock; J. Wild; M.I. Levene

Collaboration


Dive into the J. Wild's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Mark Lucock

University of Newcastle

View shared research outputs
Top Co-Authors

Avatar

M.I. Levene

Leeds General Infirmary

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

C.H. Lumb

Leeds General Infirmary

View shared research outputs
Top Co-Authors

Avatar

M. Oliver

Leeds General Infirmary

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

A.C. Dowell

Leeds General Infirmary

View shared research outputs
Top Co-Authors

Avatar

A.P. Read

Leeds General Infirmary

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge